Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Keracare dry and itchy scalp anti-dandruff - Medication Information

Product NDC Code 63766-002
Drug Name

Keracare dry and itchy scalp anti-dandruff

Type Brand
Active Ingredients
Pyrithione zinc 10 mg/ml
Route TOPICAL
Dosage Form SHAMPOO
RxCUI drug identifier 209884
Application Number M032
Labeler Name Avlon Industries, Inc.
Packages
Package NDC Code Description
63766-002-01 240 ml in 1 bottle (63766-002-01)
63766-002-02 950 ml in 1 bottle (63766-002-02)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active Ingredient Pyrithione Zinc 1%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions Apply to wet hair and gently lather with fingertips. Rinse and repeat. Leave on 5 minutes. Shampoo with KeraCare® Hydrating Detangling Shampoo for a final sudsing. For best results, follow with KeraCare® Dry & Itchy Scalp Anti-Dandruff Moisturizing Conditioner.

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive Ingredients Aqua/Water/Eau, Aloe Barbadensis Leaf Juice, Disodium Laureth Sulfosuccinate, Cocamidopropyl Betaine, Cocamide MIPA, Polysorbate 20, Sodium Cocoyl Isethionate, Cetyl Alcohol, Glycerin, Menthol, Piroctone Olamine, Pyrus Malus (Apple) Fruit Extract, Citrus Limon (Lemon) Peel Extract , Camellia Sinensis Leaf Extract, Fragrance/Parfum, Quaternium-80, Propanediol, Polyquaternium-10, Caprylyl Glycol, Phenoxyethanol, Tetrasodium EDTA, Citric Acid, Benzyl Salicylate, Hexyl Cinnamal, Linalool, Blue 1 (CI 42090).

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Use for the relief of scalp flaking, itching and irritation associated with dandruff and seborrheic dermatitis.

Purpose

Information about the drug product’s indications for use.
Purpose Anti-Dandruff, Anti-Seborrheic Dermatitis

Spl product data elements

Usually a list of ingredients in a drug product.
KeraCare Dry and Itchy Scalp Anti-Dandruff Pyrithione Zinc LINALOOL, (+/-)- WATER ALOE VERA LEAF DISODIUM LAURETH SULFOSUCCINATE COCAMIDOPROPYL BETAINE GLYCERIN POLYSORBATE 20 SODIUM COCOYL ISETHIONATE CAPRYLYL GLYCOL COCO MONOISOPROPANOLAMIDE CETYL ALCOHOL APPLE PROPANEDIOL PHENOXYETHANOL EDETATE SODIUM EDETIC ACID .ALPHA.-HEXYLCINNAMALDEHYDE MENTHOL PIROCTONE OLAMINE PIROCTONE LEMON PEEL GREEN TEA LEAF FD&C BLUE NO. 1 CITRIC ACID MONOHYDRATE BENZYL SALICYLATE SALICYLIC ACID POLYQUATERNIUM-10 (30000 MPA.S AT 2%) 2-(CYCLOHEXYLAMINO)ETHANESULFONIC ACID PYRITHIONE ZINC PYRITHIONE ZINC

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
KeraCare Dry and Itchy Scalp Anti-Dandruff Moisturizing Shampoo Product NDC 63766-002 Label

Recent major changes

A list of the section(s) that contain substantive changes that have been approved by FDA in the product labeling. The headings and subheadings, if appropriate, affected by the change are listed together with each section’s identifying number and the month and year on which the change was incorporated in the labeling.
Dosage and Administration Section Section 9 10/2019

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor before use if you have ■ seborrheic dermatitis that covers large areas of your body. -----------------------------------------------------------------------------------------------------

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if ■ Condition worsens or does not improve with regular use. -----------------------------------------------------------------------------------------------------

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product ■ Avoid getting into eyes. In event of contact, rinse eyes thoroughly with water. ■ Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application. -----------------------------------------------------------------------------------------------------

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings ■ For external use only -----------------------------------------------------------------------------------------------------

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API